PCYC
Pharmacyclics Inc
A biopharmaceutical company that made Imbruvica (ibrutinib), a pill used to treat blood cancers like chronic lymphocytic leukemia. It was founded in 1991 by chemist Jonathan Sessler and oncologist Richard Miller, who had once treated Sessler for Hodgkin's lymphoma. The name blends "pharma" with "cyclics," a nod to the cyclic molecules the founders first set out to develop, and AbbVie acquired the company in 2015.
CUSIP: 716933106HealthcareUS1 derivative reporter